Dentium CO., LTD (145720) Fair Value & Analysis
Healthcare · KR · Market cap 327B KRW
Fair value as of: Jul 22, 2026
From 14 valuation models · updated 19 days ago
Share price +2.4% over the past month.
Below-average quality, currently priced close to our fair value.
What matters now
- The price sits close to our fair value, market and models broadly agree here, little valuation tension.
- Our model range runs from 31,399 KRW (bear) to 52,331 KRW (bull), base 41,865 KRW. The closer the price sits to the lower half, the larger the margin of safety.
- Quality 40/100 (below-average quality) with medium evidence: read the verdict with care.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 22, 2026.
How to read this chart
60‑month range 36,400 KRW – 172,044 KRW · fair‑value band 31,399 KRW – 52,331 KRW · the 42,650 KRW price screens above the 41,865 KRW fair value. Dashed = 300-day average. As of Jul 22, 2026.
Analysis
Dentium CO., LTD (145720) currently trades at 42,650 KRW, while our model-based Fair Value estimate is 41,865 KRW, implying the stock looks roughly 1.8% fairly valued today. The Quality Score stands at 40/100 (below-average quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).
Over the trailing twelve months, Dentium CO., LTD generated revenue of 341B KRW at a net margin of 6.2%. Revenue declined 7.1% year over year. It earns a return on equity of 3.6%. Net debt stands at 206B KRW. Fundamentals as of Jul 22, 2026
Our scenario range runs from 31,399 KRW (bear case) to 52,331 KRW (bull case); at 42,650 KRW, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 41% below its 52-week high and 2% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -43% fair-value upside, at -2%, 145720 screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 14 models by family
Widest divergence: Economic Profit (46,602 KRW) versus Earnings-Based (18,002 KRW). Highest evidence: Residual Income (76).
Notify me when 145720 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 22, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 39 · Market factors (momentum, volatility) 29
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Dentium CO., LTD manufactures and sells dental medical instrument worldwide. Its implant systems include superline, implantium, implantium 2, N.R. line, simple line 2, and slim line. The company also provides block and coloring; regeneration products; and digital dentistry products.
Full company description
Dentium CO., LTD manufactures and sells dental medical instrument worldwide. Its implant systems include superline, implantium, implantium 2, N.R. line, simple line 2, and slim line. The company also provides block and coloring; regeneration products; and digital dentistry products. In addition, it offers orthodontics, bright resin, tooth care, and other dental products. The company was formerly known as Biostech Co., Ltd. and changed its name to Dentium Co.,Ltd. in August 2002. Dentium Co.,Ltd. was founded in 2000 and is headquartered in Seoul, South Korea.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Dentium CO., LTD reported revenue of 346B KRW in FY2025 versus 292B KRW in FY2021, a compound +4.4%/yr. Reported net income was 16.4B KRW in FY2025, compounding −26.3%/yr from FY2021.
Watch 145720: get an alert when its fair value changes →
Peer Group
Medical Instruments & Supplies · 203 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate (as of Jul 22, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Intuitive Surgical, Inc ISRG | $402.33 | $150.04 | -63% |
| EssilorLuxottica Société anonyme 1EL | €172.45 | €68.55 | -60% |
| Medline Inc MDLN | $41.11 | $30.15 | -27% |
| Becton, Dickinson and Company BDX | $150.65 | $103.53 | -31% |
| Alcon Inc ALC | $70.26 | $39.78 | -43% |
| ResMed Inc RMD | $203.87 | $187.89 | -8% |
| West Pharmaceutical Services, Inc WST | $353.71 | $143.97 | -59% |
| Straumann Holding STMN | CHF 106.00 | CHF 47.31 | -55% |
| Sartorius Stedim Biotech S.A DIM | €188.50 | €51.16 | -73% |
| Coloplast A/S COLOB | kr 414.00 | kr 382.22 | -8% |
Compare Dentium CO., LTD with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Dentium CO., LTD (145720) overvalued or undervalued?
What is the fair value of 145720?
What is the quality score of 145720?
What is the revenue of Dentium CO., LTD (145720)?
What is the net profit margin of 145720?
Does Dentium CO., LTD pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Dentium CO., LTD and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.